One or more of the indications for the medicinal product consistent with the terms of the F1UK marketing authorisation, EU marketing authorisation, certificate of registration, traditional herbal registration or Article 126a authorisation for the product F2or, in the case of a product in relation to which there is in force an authorisation by the licensing authority on a temporary basis under regulation 174, the indications for the medicinal product consistent with the recommendation or requirement of the licensing authority as to the use of that product.